Effects of an oral treatment with concentrated grape juice (ENT) on cell NOS (eNOS and iNOS) expression and proliferation in experimentally induced carcinoma in mice

Revue de Medecine Veterinaire

Volumn 159, Issue 3, 2008, Pages 123-129

  Taskin, E I ^a   Kapucu, A ^a   Akgun Dar K ^a   Yagci, A ^b   Caner, M ^c   Firat, U B ^a   Firat, I ^a   Dogruman, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ehrlich Ascite carcinoma cells; eNOS; ENT; iNOS; Mice; PCNA

Indexed keywords

ANIMALIA; MUS; VITACEAE;

EID: 41949095540     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. AHMAD N., FEYES O.K., NIEMINEN A.L., AGARWAL R., MUKHTAR H.: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst., 1997, 89, 1881-1886.
2. ANDRADE S.P., HART H.R., PIPER P.J.: Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br. J. Pharmacol., 1992, 107, 1092-1097.
3. BAGCHI D., GARG A., KROHN R., BAGCI M., BAGCI D.J., BALMOORI J., STOHS S.J.: Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen. Pharmacol., 1998, 30, 771-776.
4. BAGCHI D., GARG A., KROHN R.L., BAGCHI M., TRAN M.X., STOSH S.J.: Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res. Comm. Mol Pathol. Pharmacol, 1997, 95, 179-189.
5. BHAT K.P., PEZZUTO J.M.: Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 2002, 957, 210-229.
6. BIRT F.D., HENDRICH S., WANG W.: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Therap., 2001, 90, 157-177.
7. CALMELS S., HAINAUT P., OHSHIMA H.: Nitric oxide induces conforma-tional and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res., 1997, 57, 3365-3369.
8. CHAN M.M., FONG D., HO C.T., HUANG H.I.: Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem. Pharmacol., 1997, 54, 1281-1286.
9. CUI S., REICHNER J.S., MATED R.B., ALBINA J.E.: Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res., 1994, 54, 2462-2467.
10. DE LA LASTRA C.A., VILLEGAS I.: Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. mol. Nutr. Food Res., 2005, 49, 405-430.
11. DIAZ J.A., VARA E., MOLERO J.T., GARCIA C., BAKI W., ARMENGOL J.A.R., BALIBREA J.L.: Nitrite/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients, Cancer, 1994, 74, 1546-1550.
12. DINAPOLI M.R., CALDERON C.L., LOPEZ D.M.: Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice. J. Immunol., 1997, 158, 1810-1817.
13. DITTMER D., MOCARSKI E.S.: Human cytomegalovirus infection inhibitis G1/S transition. J. Virol., 1997, 2, 1629-1634.
14. DUE-NAS-GONZALEZ C.M., ISALES DEL MAR ABAD-HERNANDEZ M., GONZALEZ-SARMIENTO R., SANGUEZA O., RODRIGUEZ-COMMES J.: Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. odern Pathol., 1997, 10, 645-649.
15. 21/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Biochem. J., 1993, 289, 357-361.
16. FERRARI C.K., TORRES E.A.: Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomed. Pharmacother., 2003, 57, 251-260.
17. FERRER P., ASENSI M., PRIEGO S., BENLLOCH M., MENA S., ORTEGA A., OBRADOR E., ESTEVE J.M., ESTRELA J.M.: Nitric oxide mediates natural polyphenol-induced Bcl-2 down regulation and activation of cell death in metastatic B16 melanoma. J. Biol. Chem. 2007, 5, 2880-2890.
18. FITZPATRICK D.F., HIRSCHFIELD S.L., COFFEY R.G.: Endothelium dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol, 1993, 265, 774-778.
19. FLESCH M., SCHWARZ A., BOHM M.: Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am. J. Physiol., 1998, 275, 1183-1190.
20. FUJIMOTO H., ANDO Y., YAM T., TERAZAKI H., TANAKA Y., SAAKI J., MATSUMOTO M., SUGA M., ANDO M.: Nitric oxide synthase activity in human lung cancer. Jpn. J. Cancer Res., 1997, 88, 1190-1198.
21. GARDNER S.H., HAWCROFT G., HULL M.A.: Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells. Br. J. Cancer, 2004, 91, 153-163.
22. GOTO T., HARUMA K., KITADAI Y, ITO M., YOSHIHARA M., SUMII K., HAYAKAWA N., KAJIYAMA G.: Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin. Cancer Res., 1999, 5, 1411-1415.
23. GRAZIEWICZ M., WINK D.A., LAVAL F.: Nitric oxide inhibits DNA ligase activity: potential mechanism for NO-mediated DNA damage. Carcinogenesis, 1996, 17, 2501-2505.
24. HAMAOKA R., YAGINUMA Y., TAKAHASHI T., FUJII J., KOIZUMI M., SEO H. G., HATANAKA Y., HASHIZUME K., II K., HANAFUSA T., MATSUZAWA Y., ISHIKAWA M., TANIGUCHI N.: Different expression patterns of Nitric Oxide Synthase isozymes in various gynecological cancers. J. Cancer Res. Clin. Oncol., 1999, 125, 321-326.
25. HERTOG M.G., HOLLMAN P.C.: Potential health effects of the dietary flavonol quercetin. Eur. J. Clin. Nutr., 1996, 50, 63-71.
26. HIBBS J.B., VAVRIN Z., TAINTOR R.R.: L-Arginine is required for expression of the activated macrophage effector mechanism cau-sing selective metabolic inhibition in target cells. J. Immunol., 1987, 138, 550-565.
27. IMAMURA G., BERTELLI A.A., BERTELLI A., OTANI H., MAULIK N., DAS D.K.: Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am. J. Physiol. Heart Care Physiol, 2002, 282, 1996-2003.
28. IWASAKI T., HIGASHIYAMA M., KURIYAMA K., SASAKI A., MUKAIM., SHINKAI K., HORAIT., MATSUDA H., AKEDO H.: nitro-1-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model. Jpn. J. Cancer Res., 1997, 88, 861-866.
29. JENKINS D.C., CHARLES I.G., THOMSEN L.L., MOSS D.W., HOLMES L.S., BAYLIS S.A., RHODES P., WESTMORE K., EMSON P.C., MONCADA S.: Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci., 1995, 92, 4392-4396.
30. KAWADA N., SEKI S., INOUE M., KUROKI T.: Effect of anti-oxidants, resveratrol, quercetin, and N-acetylcysteine, on functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology, 1998, 27, 1265-1274.
31. KIM H.K., CHEON B.S., KIM Y.H., KIM S.Y., KIM H.P.: Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structureactivity relationships. Biochem. Pharmacol., 1999, 58, 759-765.
32. LEJEUNE P., LAGADEC P., ONIER N., PINARD D., OHSHIMA H., JEANNIN J.F.: Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol., 1994, 152, 5077-5083.
33. LIN J.K., TSAI S.H.: Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc. Natl. Sci. Counc. Repub. China, 1999, 23, 99-106.
34. LIN Y.L., LIN J.K.: Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharideinduced activity of transcription factor nuclear factor-κ-B. Mol. Pharmacol., 1997, 52, 465-472.
35. MACNAUL K.L., HUTCHINSON N.I.: Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem. Biophys. Res. Commun., 1993, 196, 1330-1334
36. MONCADA S., PALMER R.M.J., HIGGS E.A.: Nitric oxide: physiology, pathophysiology, and pharmacology. Am. Soc. Pharmacol. Exp. Ther., 1991, 43, 109-142.
37. NGUYEN T., BRUNSON D., CRESPI C.L., PENMAN B.W., WISHNOK J.S., TANNENBAUM S.R.: Damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci., 1992, 89, 3030-3034.
38. OHNO H.: Effects of testosterone on cell proliferation and apoptosis in BBN induced mouse urinary bladder carcinogenesis. Yonago Acta Med., 2000, 43, 121-130.
39. PASCHKA A.G., BUTLER R., YANG C.Y.: Induction of apoptosis in prostate cancer cell lines by the green tea component, -epigallo-catechin-3-gallate. Cancer Lett., 1998, 130, 1-7.
40. RADOMSKI M.W., JENKINS D.C., HOLMES L., MONCADA S.: Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res., 1991, 51, 6073-6078.
41. REINACHER-SCHICK A., SCHOENECK A., GRAEVEN U., SCHWARTE-WALDHOFF I., SCHMIEGEL W.: Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis, 2003, 24, 443-451.
42. REVENEAU S., ARNOULD L., JOLIMOY G., HILPERT S., LEJEUNE P., SAINT-GIORGIO V., BELICHARD C., JEANNIN JF.: Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab. Invest., 1999, 79, 1215-1225.
43. SANDOVAL M., LIU X., OLIVER P.D., ZHANG X.J., CLARK D.A., MILLER MJ.S.: Nitric oxide induces apoptosis in a human colonic epithelial cell line, T84. Mediat. Inflamm., 1995, 4, 248-250.
44. SENTURK L.M., SELI E., GUTIERREZ L.S., MOR G., ZEYNELOGLU H.B., ARICI A.: Monocyte chemotactic protein-1 expression inhuman corpus luteum. Mol. Hum. Reprod., 1999, 5, 697-702.
45. SOLEAS G., GRASS L., JOSEPHY D., GOLDBERG M.D., DIAMANDIS P.E.: A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin. Biochem., 2002, 35, 119-124.
46. SOLEAS G.J., DIAMANDIS E.P., GOLDBERG D.M.: Wine as a biological fluid: history, production and role in disease prevention. J. Clin. Lab. Anal., 1997, 5, 287-313.
47. SUGANUMA M., OKABE S., SUEOKA N., SUEOKA E., MATSUYAMA S., IMAI K., NAKACHI K., FUJIKI H.: Green tea and cancer chemoprevention. Mutat. Res., 1999, 428, 339-344.
48. SUTHERLAND B., RAHMAN R., APPLETON I.: Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J. Nutr. Biochem., 2006, 17, 291-306.
49. TAMIR S., WALKER T.D., WISHNOK J.S., TANNENBAUM S.R.: Damage and genotoxicity by nitric oxide. Methods Enzymol., 1996, 269, 230-243.
50. TASKIN E.I., YAGCI A., FIRAT U.B., CANER M., DOGRUMAN H: Tumor regressive effect of grape juice (Enoant®) on ehrlich ascites carcinoma of mice. Med. Weter., 2007, 8, 926-931.
51. THOMSEN L.L., LAWTON F.G., KNOWLES R.G., BEESLEY J.E., RIVEROS-MORENO V., MONCADA S.: Nitric oxide synthase activity in human gynecological cancer. CancerRes., 1994, 54, 1352-1354.
52. THOMSEN L.L., MILES D.W., HAPPERFIELD L., BOBROW L.G., KNOWLES R.G., MONCADA S.: Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 1995, 72, 41-44.
53. TOZER G.M., PRISE V.E., CHAPLIN D.J.: Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with 1-arginine. CancerRes., 1997, 57, 948-955.
54. VICKERS S.M., MACMILLAN-CROW L.A., GREEN M., ELLIS C., THOMPSON J.A.: Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. Arch Surg., 1999, 134, 245-251.
55. WADSWORTH T.L., KOOP D.R.: Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol., 1999, 57, 941-949.
56. WALLERATH T., DECKERT G., TERNES T., ANDERSON H., LI H., WITTE K., FORSTERMANN U.: Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation, 2002, 24, 1652-1658.
57. WALLERATH T., LI H., GODTEL-AMBRUST U., SCHWARZ P.M., FÖRSTERMANN U.: A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide, 2005, 12, 97-104.
58. YANG C.S.: Inhibition of carcinogenesis by tea. Nature, 1997, 389, 134-135.
59. YOSHIE Y., OHSHIMA H.: Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. Free Rad. Bio. Med., 1998, 24, 341-348.